Literature DB >> 3423620

Plasma fibronectin and microvascular damage in essential mixed cryoglobulinaemia.

V Toschi1, P Renoldi, A Motta, C Cimminiello, G Arpaia, G F Fiorini.   

Abstract

Plasma fibronectin (FN) was measured in 17 patients with essential mixed cryoglobulinaemia (EMC) and in 17 normal subjects by single radial immunodiffusion (RID) and enzyme-linked immunosorbent assay (ELISA). In 9 patients the presence of FN in the cryoprecipitates was also assessed by immunoblotting. In the EMC group, plasma FN levels were significantly lower than in control subjects, using both methods, and FN was constantly demonstrated in EMC cryoprecipitates. Capillaroscopic observation of the capillary bed in skin and bulbar conjunctiva, performed in all cases, showed severe alterations of microcirculation in EMC patients. A negative correlation between plasma FN and capillaroscopic abnormalities of skin capillaries was observed. These data support the hypothesis that plasma fibronectin plays a role in the pathogenesis of systemic vasculitis in EMC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3423620     DOI: 10.1007/BF00541379

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  38 in total

Review 1.  Fibronectin in disease.

Authors:  A J D'Ardenne; J O McGee
Journal:  J Pathol       Date:  1984-04       Impact factor: 7.996

2.  Affinity of myeloma IgG proteins for fibronectin.

Authors:  A Hautanen; J Keski-Oja
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

Review 3.  Physiology of fibronectin.

Authors:  D F Mosher
Journal:  Annu Rev Med       Date:  1984       Impact factor: 13.739

4.  Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis.

Authors:  M E Lanser; T M Saba; W A Scovill
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

5.  Response of plasma fibronectin to major body burn.

Authors:  J E Grossman; R H Demling; N D Duy; D F Mosher
Journal:  J Trauma       Date:  1980-11

6.  Interaction of fibronectin with complement component C3.

Authors:  A Hautanen; J Keski-Oja
Journal:  Scand J Immunol       Date:  1983-03       Impact factor: 3.487

Review 7.  Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients.

Authors:  P D Gorevic; H J Kassab; Y Levo; R Kohn; M Meltzer; P Prose; E C Franklin
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

8.  An experimental model for the study of the opsonic activity of fibronectin in the clearance of intravascular complexes.

Authors:  K W Walton; T J Almond; M Robinson; D L Scott
Journal:  Br J Exp Pathol       Date:  1984-04

9.  Fibronectin is produced by human macrophages.

Authors:  K Alitalo; T Hovi; A Vaheri
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

10.  Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes.

Authors:  C G Pommier; S Inada; L F Fries; T Takahashi; M M Frank; E J Brown
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  1 in total

1.  Lack of binding between cryoimmunoglobulins, immunoglobulins and fibronectin: implications for immune complex vasculitis.

Authors:  D T Brandau; R O'Donnell; V L Kimmel-Truitt
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.